Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.59385 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.56149 | 24 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.56833 | 24 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51067 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.50201 | 23 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.62791 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.64422 | 26 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.54336 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.53315 | 24 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.54916 | 24 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.55007 | 24 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.5418 | 25 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.55572 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.55623 | 24 |